The Medicines & Healthcare products Regulatory Agency (MHRA) is working closely with the Government to analyse the best options and opportunities available for the safe and effective regulation of medicines and medical devices in the UK.
This four-day course covers issues in regulatory science for gene and cell-therapy medicinal products.
Bringing together pioneers and policy-makers, innovators and implementers to discuss how developments in genomics, AI and digital are transforming our ability to predict and manage disease, and how policy can help move us from vision to reality in healthcare.
Join this webinar to get practical hints and tips on the different areas to consider when preparing for GMP manufacture of ATMPs. CGT Catapult subject matter experts will be drawing on their own expertise and their experience of collaborating with therapy developers at the CGT Catapult manufacturing centre.
The BIO International Convention is hosted by the Biotechnology Innovation Organization (BIO), which represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations.